Company Search:
Advanced Search
Sponsored Links
Neovacs SA Company Snapshot
Neovacs SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neovacs SA with three other miscellaneous service companies in Europe: Shield Therapeutics PLC of the United Kingdom (2017 sales of £637,000.00 [US$892,156.72 ] ), Gunsynd PLC of the United Kingdom (£825,000.00 [US$1.16 million] ), and Inno-Gene SA which is based in Poland (2.92 million Polish New Zlotys [US$860,925.54 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Neovacs SA
  Stock Performance Chart for Neovacs SA
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): .40
(Figures in Euro)
1 Week -5.2%   13 Weeks -10.7%  
4 Weeks -23.6%   52 Weeks -50.5%  
Neovacs SA Key Data:
  Ticker: ALNEV Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 834,000
(Year Ending Jan 2018).
Employees: 19
  Currency: Euro Market Cap: 21,090,940
  Fiscal Yr Ends: December Shares Outstanding: 52,595,860
  Share Type: Closely Held Shares: 1,652,960
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.